Key facts
- This page summarizes E&Investment, Inc.'s Form 4 filing for NeuroBo Pharmaceuticals, Inc. (MTVA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 28 Jul 2022, 21:23.
E&Investment, Inc. - 26 Jul 2022 Form 4 Insider Report for NeuroBo Pharmaceuticals, Inc. (MTVA)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- MTVA
- Reported as of
- 26 Jul 2022
- Net transaction value
- $0
- Reporting owner signature
- /s/ E&I Investment, Inc., By: Na Yeon Kim, CEO
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
E&Investment, Inc. filed Form 4 for NeuroBo Pharmaceuticals, Inc. (MTVA) on 28 Jul 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NRBO
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- -1,445,267
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 2,890,533
- Date
- 26 Jul 2022
- Ownership
- Held by The E&Healthcare Investment Fund II
- Footnotes
- F1, F2, F3
NRBO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 140,147
- Date
- 26 Jul 2022
- Ownership
- Direct
- Footnotes
- F4
NRBO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,121,190
- Date
- 26 Jul 2022
- Ownership
- Held by The E&Healthcare Investment Fund No. 6
- Footnotes
- F3, F5
NRBO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,864,799
- Date
- 26 Jul 2022
- Ownership
- Held by The E&Healthcare Investment Fund No. 7
- Footnotes
- F3, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
E&Healthcare Investment Fund II distributed 1,445,267 shares to its partners on a pro rata basis, for no consideration.
Footnote F2
These shares are owned directly by The E&Healthcare Investment Fund II, a 10% owner of the Issuer, and indirectly by its sole general partner, E&Investment, Inc.
Footnote F3
E&Investment, Inc. disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
Footnote F4
E&Investment, Inc. received a pro rata distribution from E&Healthcare Investment Fund II.
Footnote F5
These shares are owned directly by The E&Healthcare Investment Fund No. 6, and indirectly by its sole general partner, E&Investment, Inc.
Footnote F6
These shares are owned directly by The E&Healthcare Investment Fund No.7, and indirectly by its sole general partner, E&Investment, Inc.